ASX Announcements / Media releases

28 June 2022

BCAL Enters US Product Development Agreement with Precion. Read more

1 June 2022

BCAL Presentation Accepted for 2022 ASCO Annual Meeting. Read more

12 May 2022

BCAL Files Foundational Patent Application. Read more

24 Mar 2022

Shareholder Newsletter. Read more

8 Feb 2022

7 February Announcement - Additional Information. Read more

7 Feb 2022

Recent Analysis Significantly Improves Commercial Prospects. Read more

11 Jan 2022

Dr John Hurrell Appointed Chief Executive Officer. Read more

3 Nov 2021

Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test. Read more

21 Oct 2021

Notice of Annual General Meeting and Explanatory Statement. Read more

3 Sep 2021

Australian Clinical Studies Launched. Read more

17 Aug 2021

Market Update. Read more

22 July 2021

Becoming a substantial holder. Read more

21 July 2021

BCAL Diagnostics to list after raising $10m in IPO. Read more